Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

98
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
98
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

73
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
73
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

88
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
88
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

79
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
79
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

172
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
172

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving Vaccination in People With CKD: Report From a National Kidney Foundation Working Group.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2025
Same author

Tacrolimus dosing in liver transplant recipients using phenotypic personalized medicine: A phase 2 randomized clinical trial.

Nature communications·2025
Same author

Deceased Donor Renal Allograft Utility in Adult Single and Multi-organ Transplantation in the United States.

Transplantation direct·2024
Same author

Changing landscape of liver transplant in the United States-<i>time for a new innovative way to define and utilize the "non-standard liver allograft"-a proposal</i>.

Frontiers in transplantation·2024
Same author

A propensity score matched analysis of liver transplantation outcomes in the setting of preservation solution shortage.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2023
Same author

Personalized Tacrolimus Dosing After Liver Transplantation: A Randomized Clinical Trial.

medRxiv : the preprint server for health sciences·2023

Related Experiment Video

Updated: Oct 9, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K

Kidney transplant program specific reporting and transplant metrics.

Kenneth A Andreoni1

  • 1University Hospitals Cleveland Medical Center, Case Western Reserve University, Department of Surgery, Division of Transplantation and Hepatobiliary Surgery, Cleveland, Ohio, USA.

Current Opinion in Organ Transplantation
|December 23, 2021
PubMed
Summary

Stricter kidney transplant regulations may lead to more underperforming centers and increased waiting list deaths. The Health Resources and Services Administration should create a more flexible regulatory environment for kidney transplantation.

More Related Videos

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
09:00

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients

Published on: April 13, 2021

4.8K
Murine Kidney Transplant Technique
08:58

Murine Kidney Transplant Technique

Published on: October 20, 2015

16.5K

Related Experiment Videos

Last Updated: Oct 9, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K
TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
09:00

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients

Published on: April 13, 2021

4.8K
Murine Kidney Transplant Technique
08:58

Murine Kidney Transplant Technique

Published on: October 20, 2015

16.5K

Area of Science:

  • Nephrology
  • Transplant Surgery
  • Health Policy

Background:

  • Kidney transplantation is regulated by the Secretary of HHS under the NOTA and Final Rule.
  • Transplant programs are evaluated every six months based on a 2.5-year outcome period.
  • Current Bayesian metrics flag over 10% of kidney transplant programs as underperformers biannually.

Purpose of the Study:

  • To review the impact of current and proposed kidney transplant metrics.
  • To discuss the implications of proposed changes on transplant centers and patient outcomes.
  • To advocate for a more adaptive regulatory environment in kidney transplantation.

Main Methods:

  • Analysis of current kidney transplant evaluation metrics.
  • Review of newly proposed transplant metrics for public comment (Summer 2021).
  • Assessment of the correlation between transplant center flagging and transplantation rates.

Main Results:

  • Proposed metrics are expected to flag over 10% of kidney transplant programs.
  • Transplant center flagging is linked to reduced transplantation rates due to conservative patient and organ acceptance.
  • Waiting list mortality is a proposed metric, yet centers have limited influence over it.

Conclusions:

  • Current and proposed regulations, enforced by HRSA, OPTN, and SRTR, contribute to high organ discard rates and limit transplants for at-risk patients.
  • Proposed metrics may penalize transplant centers unfairly, potentially increasing waiting list mortality.
  • HRSA should foster a regulatory environment that supports innovation and expands transplant opportunities for end-stage renal disease patients.